Drug Profile
Research programme: indolinone derivatives - SUGEN
Alternative Names: Indolinone derivatives research programme - SUGEN; SU 5614; SU 6577; SU 6663; SU-4984Latest Information Update: 29 Feb 2008
Price :
$50
*
At a glance
- Originator SUGEN
- Class Small molecules
- Mechanism of Action Proto oncogene protein c-kit inhibitors; Type 1 fibroblast growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Oct 2000 Preclinical development for Cancer in USA (Unknown route)